RPL32P18

Across TCGA pan-cancer cohorts, RPL32P18 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RPL32P18’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL32P18 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P18 is over-expressed in tumor, although a few such as HNSC and BRCA show the opposite, repressed pattern.

COAD, KIRP, and LIHC are the cancer types where RPL32P18 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P18 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+2.313	<.001	11	view →
KIRP	Male	III,IV	+0.662	<.001	8	view →
LIHC	All	II,III,IV	+0.842	.001	6	view →
KIRC	Male	All	+0.468	<.001	6	view →
HNSC	Female	II,III,IV	−0.885	.001	5	view →
BRCA	Female	All	−0.496	<.001	4	view →
CHOL	Male	All	+1.446	.005	2	view →
READ	All	All	+0.661	.012	2	view →
THCA	Female	II,III,IV	+0.580	.014	2	view →
PRAD	All	All	+0.367	.005	2	view →
KICH	Female	All	−0.592	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

RPL32P18–COAD

Open the COAD breakdown →